Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Stribild

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Abstract Single tablet combination of tenofovir disoproxil fumarate, emtricitabine, elvitegravir and cobicistat [TDF/FTC/EVG/COBI… Expand
2014
2014
Switch to Stribild (STB) was non‐inferior to continuation of a non‐nucleoside reverse transcriptase inhibitor (NNRTI) with… Expand
2014
2014
Simplification to Stribild (STB) was statistically superior to continuation of a ritonavir‐boosted protease inhibitor (PI+RTV… Expand
Review
2014
Review
2014
Human immunodeficiency virus type 1 (HIV-1) integrase inhibitors belong to a novel class of antiretroviral drugs with high… Expand
  • table 1
  • figure 1
2014
2014
Cobicistat, a component of stribild (STB), is known to inhibit renal creatinine secretion. A detailed analysis of the renal… Expand
Review
2014
Review
2014
Abstract Single tablet regimens (STR) have recently been expanded with the first integrase inhibitor based regimen containing… Expand
2013
2013
IntroductionIn August 2012, the US Food and Drug Administration (FDA) approved a new single tablet once-a-day therapy for… Expand